Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

This study has been completed.
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: September 6, 2005
Last updated: August 5, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)